Outcomes of rectal resection following neoadjuvant therapy in the elderly: Can rectal cancer patients be too old for a neoadjuvant approach? - 24/04/18
Abstract |
Background |
Neoadjuvant therapy has improved outcomes of resection for rectal carcinoma, however, there is limited data regarding its impact on elderly patients.
Methods |
A retrospective review of 109 patients, 74 patients <70 years (Group 1) vs 35 elderly patients ≥ 70 years (Group 2), who underwent neoadjuvant therapy followed by open resection from 1999 to 2010.
Results |
Neoadjuvant therapy was completed by 73/74 patients in Group 1 (99%) vs 30/35 patients in Group 2 (86%) (p = 0.013). R0 resection was accomplished in 94% (Group 1–96%, Group 2–91%). The overall recurrence rate was 12% for Group 1 vs 9% for Group 2. Kaplan-Meier analysis revealed a statistically significant difference in overall survival favoring Group 1 (p = 0.002).
Conclusions |
Neoadjuvant therapy was safely administered to completion in 86% of elderly patients with similar rates of R0 resection and recurrence versus a younger patient population and should not be denied on the basis of advanced age alone.
Le texte complet de cet article est disponible en PDF.Keywords : Rectal cancer, Neoadjuvant chemoradiotherapy, Neoadjuvant therapy, Outcomes, Elderly
Plan
Disclosures: None. |
Vol 215 - N° 3
P. 436-439 - mars 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?